Namaste Technologies Bringing Telemedicine for Medicinal Marijuana to Canada
Namaste Technologies is rolling out a telemedicine portal to connect doctors to medical marijuana patients virtually. The company's co-founder and CEO Sean Dollinger explains how they are bringing this technology to the Canadian market.
"NamasteMD is the first application allowed by the app store for telemedicine in Canada ever for cannabis," said Dollinger. He explains his hope for Namaste Technologies to become a global leader in cannabis by leveraging its technology for partners in the market.
The company is projecting $30 million in revenue for this year.
Namaste Technologies launched in 2014 as a hardware company producing vaporizers. "It allowed us to develop a platform that collected a database and customers around the world," said Dollinger.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
